Structural Heart Devices Market is Expected to Reach to $12,076 Million with top key players Medtronic plc; St. Jude Medical, Inc., Braile Biomedica, Medical Technology Est., Boston Scientific Corporation; Micro Interventional Devices, Inc., Edwards Lifes

Structural Heart Devices Market Report, published by Allied Market Research, forecasts that the global market was valued at $6,006 million in 2015, and is expected to reach $12,076 million by 2022, supported by a CAGR of 10.5% during the forecast period 2016 - 2022. The structural heart repair devices segment held nearly half of the total market share in 2015, and is expected to dominate during the forecast period.

Rise in incidence of aortic stenosis, introduction of technologically advanced products (such as the Trifecta valve with Glide Technology), and increase in awareness about the benefits and availability of structural heart devices worldwide are major factors that drive the market growth. In addition, increase in number of application areas for repair and replacement devices coupled with its rise in adoption of annuloplasty rings and tissue valves is expected to further fuel this growth. However, stringent approval process and high cost of surgeries restrict the market growth.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-sample/1768?utm_source=Prathm_OPR

Tissue heart valves is expected to maintain its dominant position throughout the analysis period, due to its significant property of low requirement of anticoagulants, which reduces incidence of bleeding and thereby lowers the usage of anticoagulant by the patient.

Key Findings of Structural Heart Devices Market:

• Annuloplasty ring is projected to grow at the highest growth rate during the analysis period.

• North America dominated the global structural heart devices market, accounting for one-third of the overall market in 2015, owing to the increase in prevalence of structural heart diseases.

• Aortic valve stenosis indication occupied more than one-third of the total market in 2015.

• Adult age group segment is expected to grow at the highest rate of 11.1%.

• China occupied one-fifth of the total Asia-Pacific structural heart devices market in 2015.

The occluders segment accounted for two-fifths of the overall structural heart repair devices market in 2015, owing to its benefits in the treatment of congenital heart diseases and high adoption rate. In addition, annuloplasty ring is projected to register the highest CAGR of 13.3% during the forecast period.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/1768?utm_source=Prathm_OPR

Asia-Pacific is the fastest growing region in the structural heart devices market, and is expected to continue this trend due to increase in healthcare infrastructural development, specifically in China, India, and other developing economies, and rise in structural heart defects.

Structural heart devices are used to treat heart valves defects as well as acquired valvar abnormalities. The market for structural heart devices is growing at a rapid pace, providing an opportunity for key players to enter this market. For instance, in May 2016, Johnson & Johnson announced that will enter structural heart devices market due to the high growth potential.

Top key players in the market :

• Medtronic plc; St. Jude Medical Inc.
• Braile Biomedica; Medical Technology Est.
• Boston Scientific Corporation
• Micro Interventional Devices Inc.
• Edwards Lifesciences Corporation
• LivaNova PLC
• JenaValve Technology Inc.
• Cryolife Inc.

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/structural-heart-devices-market?utm_source=Prathm_OPR

Table of content :

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.1.1. Key benefits for stakeholders
1.1.2. Key market segments

1.2. RESEARCH METHODOLOGY

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.2.3. Market share analysis, 2015

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in number of patients suffering from structural heart diseases
3.3.1.2. Increase in risk of cardiovascular diseases owing to growing globalization and industrialization
3.3.1.3. Technological advancements in heart repair and replacement devices
3.3.1.4. Growth in demand for minimally invasive procedures

3.3.2. Restraints

3.3.2.1. High cost and risk associated with the treatment procedures
3.3.2.2. Stringent approval process for structural heart devices

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies

3.4. MITRACLIP MITRAL VALVE REPAIR SYSTEM
3.5. GOVERNMENT REGULATIONS

3.5.1. FDA
3.5.2. Health Canada
3.5.3. CE Mark
3.5.4. Ministry of Health, Labour and Welfare (MHLW)
3.5.5. Therapeutic Goods Administration (TGA)

3.6. REIMBURSEMENT SCENARIO
3.7. CLINICAL TRIALS

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.